Skip to content
New study concludes continuous wireless monitoring of a mother’s temperature during labor promises to be more effective than manual measurements for indicating the risk of early onset sepsis in newborn babies

News -

New study concludes continuous wireless monitoring of a mother’s temperature during labor promises to be more effective than manual measurements for indicating the risk of early onset sepsis in newborn babies

A new study has concluded that the use of a continuous wireless patient monitoring platform which monitors a mother’s temperature during labor could aid detection of newborns at risk of the early onset of sepsis (EOS) faster than current practice, enabling earlier and more effective targeted treatment of affected infants.

Maternal fever during labor is the strongest predictor of EOS. Current standard obstetric practice is to measure oral temperature intermittently which means symptoms of fever can sometimes be missed. Using the Patient Status Engine, a wireless monitoring platform designed and developed by Isansys Lifecare, a clinical team at Cohen Children’s Medical Center in New York, compared continuous and intermittent (standard care) temperature data from over 150 women during labor. They concluded that continuous measurement of maternal temperature provides better data than manual oral observations for predicting which babies may have a higher risk of infection in their first few days of life.

“Wireless continuous temperature measurements are feasible and practical and provide a more accurate assessment of maternal fever during labor,” said the team carrying out the efficacy study. “Current measurements of maternal temperature during labor are invasive, unpleasant, intermittent and somewhat subjectively performed. Continuous temperature monitoring during labor contributes to a more accurate assessment of risk to the early-onsets of sepsis and facilitates timely and appropriate treatment of infection, improving clinical outcomes for newborns.”

The wireless measurements in the study were taken with the Isansys Lifetemp, a continuous real-time clinical thermometer. Other parameters including heart rate, respiration rate and heart rate variability were also measured on the mothers using the Isansys Lifetouch, a CE / FDA certified and wireless cardiac sensor. These new and very large datasets are currently being analysed to see if there is hidden information that could provide additional insights relating to maternal temperature and other physiological mechanisms that may have significance during labor.

Read the full results from the paper “Efficacy of continuous monitoring of maternal temperature during labor using wireless axillary sensors” here.

Topics

Categories

Contacts

Georgina Horton

Georgina Horton

Press contact Head of Communications 01235 436225

Providing extraordinary new digital medical tools to transform patient data into valuable clinical insight

Isansys provides remote monitoring solutions which improve patient care, drive clinical performance, ensure economic value and enhance patient safety.

Headquartered in Oxfordshire, with subsidiaries in Germany, India and the US, Isansys is a privately limited company which was founded in 2010 by Keith Errey and Rebecca Weir.

Our business is to work with health professionals, insurance companies and healthcare organisations to provide more efficient patient monitoring against a backdrop of staff shortages and a rising number of patients and costs and limited budgets.

All our products and devices are fully certified and qualified medical devices.

Isansys
8C Park Square
OX14 4RR Oxford
United Kingdom